FPM’s April 2021 events
Posted on: Thursday 1 April 2021
Author: FPM
Find out about FPM’s upcoming training and events for April 2021:
FPM JOURNAL CLUB
Wednesday 14 April 2021, 12:00 – 13:00
This month’s FPM Journal Club will take place at lunchtime on Wednesday 14 April 2021. For our upcoming session we welcome guest host Dr Mehbub Shafi.
Mehbub has chosen to review:
‘Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparatorecontrolled VOYAGE 2 trial.’
Reich et al (2016) J Am Acad Dermatol
http://dx.doi.org/10.1016/j.jaad.2016.11.042
“For my review, I chose to focus on Psoriasis, a condition in which I have personal insight, including its effect on patients both clinically and psycho-socially. The paper I chose to review was the VOYAGE 2 clinical trial. (Efficacy and safety of Guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator controlled VOYAGE 2 trial)”
Please note that this members-only event is free to attend but registration is required.
ABPI-FPM WEBINAR
Applying the ABPI Code of Practice Principles
Thursday 15 April 2021, 10:15 – 11:15
With the new ABPI Code of Practice coming into effect on 1 July 2021, FPM are supporting a series of three webinars designed to help medical directors and other leaders in embedding the new ABPI principles within their organisations.
The ABPI principles embody the spirit of the Code and cover four areas:
- patients,
- integrity,
- transparency and
- respect.
The webinars will review best practice in fostering principle-based ways of working and will review the specific ABPI Principles. The sessions will be interactive and allow attendees to share their experiences and ask questions.
The first webinar in this series takes place on Thursday 15 April and will introduce the role of the principles in underpinning the ABPI Code and system of self regulation.
DPM TRAINING, MODULE TWO
Non-Clinical Testing & Clinical Pharmacology
15 – 16 April 2021
The next module in our DPM training series will cover the following topics:
- Non-Clinical Safety Testing & Safety Testing of Small Molecules vs. Biologicals
- Principles of Pharmacokinetics
- Factors Affecting Pharmacokinetics
- Mechanisms of Action and Interaction
- Exploratory Development & Phase 0 Trials, Biosimilars, Pharmacogenetics & Pharmacogenomics
- Biomarkers, Clinical Endpoints & Surrogate Endpoints
- First in Human Studies, Dose Selection & Risk Minimisation
- Prescribing for Special Populations
- Advanced Therapies & Drug-Coupled Devices
- Pharmaceutical Development
Please note that all DPM training modules are standalone events and you don’t need to have attended previous sessions.
The DPM Training Programme is a well-designed and well-structured course that covers all aspects related to pharmaceutical medicine. The presenters are engaging and very knowledgeable about the topics. I would highly recommend this course.
P. Ryan, Nucleus Network (March 2021)
I thoroughly enjoyed and recommend the course. Its content targeted a wide theoretical knowledge of pharmacovigilance very pertinent to everyday activities of a safety physician.
Trainee (March 2021)
This course is as good as the reputation suggests! Really worth attending if possible. Great to have such detail covered and access to knowledgable speakers. Thank you!
Trainee (March 2021)
FPM CONSULTATION WORKSHOP
Women’s Health Strategy: Call for Evidence
23 April 2021 | 12.00 – 14.00
FPM members are invited to join a one-off virtual workshop to develop the FPM response to the UK Department of Health and Social Care’s Women’s Health Strategy: Call for Evidence.
This is a vital and timely consultation and we will focus on developing FPM policy on women in the workforce, and research into women’s health (including research in pregnancy, older women and women of ethnic minorities). We will also examine the effect of the COVID-19 pandemic on women’s health.